The Executive team has a proven track record in moving rapidly from scientific concepts to clinical development.

The achievement of our goals is largely driven by the competences and the skills of the ASIT biotech employees. Expertise, professional experience and commitment are at the heart of our business. It is through the dedicated work of ASIT biotech's teams that breakthrough allergy immunotherapy drugs are invented and further developed for commercialization.

Executive management team

Thierry Legon

Thierry Legon
CEO

Ir. Agronomy, MBA, Thierry Legon was in charge for ten years of the management of the intellectual property and technology transfer of the University of Brussels (ULB). Thierry was also a board member of Euroscreen (a drug discovery biotech company) for eight years.

In May 1997, Thierry founded ASIT biotech as a spin-off company of the ULB. As Chief Executive Officer (CEO) since 2000, Thierry has successfully designed consecutive business plans, raised the required funds and is leading the team to achieve the goals of the company.

Everard van der Straten

Everard van der Straten
CFO

Everard van der Straten holds a master from Solvay Business School. After a short career as auditor at Arthur and Anderson & Co, Everard was managing director of Metallo-Chimique Group and afterwards Board Member of the Metallum Group until end 2008. Currently, Everard is as well Business Angel.

Philippe Ghem

Philippe Ghem
Chief Commercial Officer

Commercial Engineer from the Solvay Business School and holder of a license in Business and Marketing from HEC Saint Louis (now ICHEC, Brussels), Philippe Ghem brings over 20 years of commercial expertise in the pharmaceutical industry (retail, hospital, vaccines, devices) gained in sales and marketing positions of big pharma (ABBOTT, GSK, NOVARTIS) and specialty companies (COLOPLAST, GRUNENTHAL). In recent positions he was also regularly involved in Market Access and Business Development activities. Philippe Ghem joined ASIT Biotech in April 2018 as Chief Commercial Officer.

Vincent Bille

Vincent Bille
Vice-President CMC

Holder of a PhD in Biochemistry from the University of Namur and a Master in Business Administration (IAG) from the Catholic University of Louvain-La-Neuve, Vincent Bille started his career at UCB as Head of the Peptide Department within the contract manufacturing division and became Director Commercial Operations, North America and General Manager US. He was then Director Sales & Business Development for Lonza in the US and Europe. In 2007, he founded Marble Pharma Consult sprl which provides consultancy services in externalized development and manufacturing operations. Vincent Bille joined ASIT Biotech as Head of CMC in 2016 to manage the manufacturing of the ASIT products.

Sabine Pirotton

Sabine Pirotton
Head of Research and Development

Holder of a PhD in Biochemistry from the Free University of Brussels, Sabine Pirotton joined ASIT Biotech in 2005 after 20 years as a Senior Scientist at the University of Brussels and Namur. She is a co-inventor of most of the patents filed by ASIT biotech. Today, Sabine Pirotton is Head of Research and Development, and continues to explore new promising drug candidates with her dedicated team.

Marie Etienne PINELLI

Marie-Etienne Pinelli
Chief Medical Officer

Doctor of Medicine from Paris V University, Marie-Etienne Pinelli brings 20 years of clinical development experience in companies such as Roche Pharmaceuticals and UCB Pharma where she managed the clinical development of Zyrtec and Xyzal, leading drugs in the allergy field. Marie-Etienne Pinelli joined ASIT biotech in November 2017 as Chief Medical Officer to take over the clinical development and medical affairs at ASIT biotech.

Vincent Theunissen

Vincent Theunissen
Head of Human Resources

Graduate from the University of Louvain, Vincent Theunissen holds a Master’s degree in psychology. He started his career at Carrefour then joined IKEA in 2005 to manage the HR Department and participate to the opening of a new store in Arlon. In 2008, Vincent joined Premier Farnell European Distribution Center as Human Resources Manager Benelux. In 2010, he was appointed Senior Vice President Human Resources at EVS SA, a Belgian company providing broadcast solutions. Vincent Theunissen joined ASIT biotech in June 2017 as Head of Human Resources.